MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
Watch Listen Read
Login Nexus Watchlists Settings
  • MARKETSnap
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
    • Investment Compounding Calculator
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
Theme Style
Switch to Dark Mode
PACB stock logo

PACB

Pacific Biosciences of California, Inc.

$1.38
0.12
 (9.52%)
Exchange:   NASDAQ
Market Cap:   414.512M
Shares Outstanding:   27.739M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Christian O. Henry
Full Time Employees:  575
Address: 
1305 O’Brien Drive
Menlo Park
CA
94025
US
Website:  https://www.pacb.com
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio’s Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Click to read more…

Revenue Segmentation

πŸ”’ You are currently logged out

Login

EPS

πŸ”’ You are currently logged out

Login
View full analyst estimates

Earnings Call

πŸ”’ You are currently logged out

Login
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

(* All numbers are in thousands)

πŸ”’ You are currently logged out

Login

Balance Sheet

(* All numbers are in thousands)

πŸ”’ You are currently logged out

Login

Cash Flow Statement

(* All numbers are in thousands)

πŸ”’ You are currently logged out

Login

Analyst Estimates

(* All numbers are in thousands)

πŸ”’ You are currently logged out

Login

Current Key Metrics

πŸ”’ You are currently logged out

Login

Forward P/E Ratios

πŸ”’ You are currently logged out

Login

SWOT Analysis

πŸ”’ You are currently logged out

Login

At what price to buy it? –
Intrinsic Value Calculator

πŸ”’ Premium Feature

Log in to access the PACB Intrinsic Value Calculator

πŸ”‘ Log In
πŸ“ Sign Up Free

Get comprehensive stock analysis with premium features

πŸ”’ You are currently logged out

Login
MS_Stock_Embed class not found. Please check plugin configuration.

Relevant news

06-08-2025 09:00
PacBio to Present at Upcoming Investor Conferences